| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Heilongjiang ZBD Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.52 |
| 52 Week High | CN¥14.37 |
| 52 Week Low | CN¥8.89 |
| Beta | 0.32 |
| 11 Month Change | 16.01% |
| 3 Month Change | 6.08% |
| 1 Year Change | -5.50% |
| 33 Year Change | -28.09% |
| 5 Year Change | -0.35% |
| Change since IPO | -32.20% |
Recent News & Updates
Getting In Cheap On Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHSE:603567) Is Unlikely
Oct 18
Heilongjiang ZBD Pharmaceutical (SHSE:603567) Seems To Use Debt Quite Sensibly
Sep 26Recent updates
Getting In Cheap On Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHSE:603567) Is Unlikely
Oct 18Heilongjiang ZBD Pharmaceutical (SHSE:603567) Seems To Use Debt Quite Sensibly
Sep 26Does Heilongjiang ZBD Pharmaceutical (SHSE:603567) Have A Healthy Balance Sheet?
May 28Why Heilongjiang ZBD Pharmaceutical's (SHSE:603567) Earnings Are Better Than They Seem
May 06Insufficient Growth At Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHSE:603567) Hampers Share Price
Apr 17Shareholder Returns
| 603567 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.8% | -5.6% | -4.4% |
| 1Y | -5.5% | -3.6% | 0.05% |
Return vs Industry: 603567 underperformed the CN Pharmaceuticals industry which returned -3.6% over the past year.
Return vs Market: 603567 underperformed the CN Market which returned 0.1% over the past year.
Price Volatility
| 603567 volatility | |
|---|---|
| 603567 Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in CN Market | 11.3% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 603567 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603567's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 2,545 | n/a | www.zbdzy.com |
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.
Heilongjiang ZBD Pharmaceutical Co., Ltd. Fundamentals Summary
| 603567 fundamental statistics | |
|---|---|
| Market cap | CN¥10.82b |
| Earnings (TTM) | CN¥763.09m |
| Revenue (TTM) | CN¥3.25b |
14.2x
P/E Ratio3.3x
P/S RatioIs 603567 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603567 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.25b |
| Cost of Revenue | CN¥1.50b |
| Gross Profit | CN¥1.75b |
| Other Expenses | CN¥985.90m |
| Earnings | CN¥763.09m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 30, 2024
| Earnings per share (EPS) | 0.81 |
| Gross Margin | 53.84% |
| Net Profit Margin | 23.49% |
| Debt/Equity Ratio | 41.2% |
How did 603567 perform over the long term?
See historical performance and comparison